What Peptides Help With Longevity?

Peptide Therapy in Longevity Medicine

Longevity medicine is no longer simply about adding years to life, it is about adding life to years. Peptide therapy has emerged as one of the most scientifically compelling tools in the longevity medicine toolkit, targeting the fundamental biological mechanisms of aging: mitochondrial dysfunction, cellular senescence, epigenetic drift, impaired autophagy, stem cell exhaustion, and hormonal decline. Here we explore the peptides with the most compelling evidence for longevity applications.

Epitalon: Telomerase Activation

Epitalon (epithalon) is a tetrapeptide, just four amino acids, that activates telomerase, the enzyme responsible for maintaining telomere length.^[1][2] Telomeres are the protective caps on chromosome ends that shorten with each cell division; critically short telomeres trigger cellular senescence or apoptosis, contributing directly to aging and age-related disease. Epitalon was developed by Dr. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, where it has been studied for over 40 years in both animal models and human trials. It has demonstrated telomerase activation, antioxidant effects, normalization of circadian melatonin rhythms, and in several long-term studies, reductions in mortality and age-related disease incidence. It is typically administered in periodic courses of 10, 20 days.

Pinealon: Neuroprotection and Circadian Support

Pinealon is another Khavinson-developed tripeptide (Glu-Asp-Arg) targeting the pineal gland and central nervous system. It has demonstrated neuroprotective effects, improved cognitive function in aging models, enhanced pineal gland activity (including melatonin regulation), and reduction of oxidative stress in neuronal tissue. In the context of longevity medicine, Pinealon represents a targeted approach to brain aging, one of the most important determinants of both lifespan and healthspan.

MOTS-c: Mitochondrial Metabolic Regulation

MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is a peptide encoded by mitochondrial DNA^[3], a remarkable distinction that reflects its evolutionary role as an intracellular metabolic regulator. MOTS-c activates AMPK (AMP-activated protein kinase), often called the 'metabolic master switch,' improves insulin sensitivity, increases fat oxidation, reduces obesity and metabolic syndrome markers, and extends lifespan in mouse models. It has been called an 'exercise mimetic' because its metabolic effects closely parallel those of physical exercise at the cellular level, a property with profound implications for aging patients with reduced exercise capacity.

Thymosin Alpha-1: Immune Restoration

Thymosin Alpha-1 is an endogenous peptide produced by the thymus gland^[4] , an immune organ that involutes (shrinks) progressively after puberty, contributing to the immune senescence of aging. TA1 restores and enhances T-cell and NK-cell function, has been used clinically for hepatitis B and C (FDA-approved in multiple countries), cancer adjunct therapy, and chronic infection. In longevity medicine, TA1 addresses one of the hallmarks of biological aging: immunosenescence, or the progressive decline in immune surveillance and response that allows cancer, chronic infection, and autoimmune dysregulation to flourish in older adults.

GHK-Cu: Tissue Repair and Gene Regulation

GHK-Cu (glycine-histidine-lysine copper complex) is an endogenous tripeptide with copper that declines dramatically with age.^[5] At youthful levels, GHK-Cu stimulates collagen synthesis, activates antioxidant defense systems, promotes wound healing, has anti-inflammatory effects, and remarkably, resets the gene expression profile of aged or damaged cells toward a more youthful state. Research by Dr. Loren Pickart identified GHK-Cu as capable of upregulating approximately 30% of the human genome in a beneficial, regenerative direction. It is used topically for skin regeneration and systemically via peptide injection for broader regenerative and anti-aging applications.

Growth Hormone Secretagogues for Longevity

Growth hormone secretagogue therapy with CJC-1295 and Ipamorelin remains one of the most clinically applied longevity peptide protocols.^[6][7] GH deficiency is a universal feature of biological aging, GH pulsatility declines by approximately 15% per decade after young adulthood. Restoring physiological GH pulsatility through secretagogue therapy supports lean mass preservation, fat loss (particularly visceral fat), bone density, skin thickness, sleep architecture (slow-wave sleep increases), cellular repair, and cognitive function, a multi-system longevity intervention delivered through the body's own pituitary.

The Lamkin Clinic, Edmond Oklahoma | lamkinclinic.com

References and Further Reading

1. [1]Khavinson VKh, et al. Epitalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-592.
2. [2]Anisimov VN, et al. Effect of epitalon on the lifespan increase in Drosophila melanogaster. Mech Ageing Dev. 2004;125(10-11):769-773.
3. [3]Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454.
4. [4]Goldstein AL, et al. Thymosin alpha1: biology and therapeutic implications in malignancy, autoimmune diseases, infectious diseases, and vaccine adjuvanticity. Ann N Y Acad Sci. 2009;1194:1-10.
5. [5]Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987.
6. [6]Teichman SL, et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295 in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805.
7. [7]Rudman D, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990;323(1):1-6.